AIDS experts reveal plan to treat B.C.’s vulnerable

Dr. Montaner said he could envision a program in which HIV-positive patients who are also addicts would receive daily anti-retroviral drugs at the same clinic where they received drug-addiction therapy. The HIV-treatment plan would have to be tailor-made for each individual.

Leave a Reply

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025